William B. Walkup & Associates’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$572 Hold
23
﹤0.01% 255
2026
Q1
$330 Hold
23
﹤0.01% 161
2025
Q4
$258 Hold
23
﹤0.01% 166
2025
Q3
$266 Hold
23
﹤0.01% 162
2025
Q2
$282 Hold
23
﹤0.01% 160
2025
Q1
$330 Hold
23
﹤0.01% 160
2024
Q4
$366 Hold
23
﹤0.01% 158
2024
Q3
$552 Hold
23
﹤0.01% 155
2024
Q2
$458 Buy
+23
New +$448 ﹤0.01% 155

Other funds holding AVNS

William B. Walkup & Associates's AVNS Position: Q2 2026 in Review

William B. Walkup & Associates held its Avanos Medical (AVNS) position steady in Q2 2026 at 23 shares worth $572. The position accounts for ﹤0.01% of the portfolio, ranked #255.

William B. Walkup & Associates first reported a position in AVNS in Q2 2024 and has held it in 9 quarters since. 78 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • William B. Walkup & Associates held 23 shares of Avanos Medical worth $572 as of Q2 2026.
  • William B. Walkup & Associates left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of William B. Walkup & Associates's portfolio in Q2 2026, its #255 holding.
  • William B. Walkup & Associates first reported a position in Avanos Medical in Q2 2024 and has held it in 9 quarters since.
  • 78 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on William B. Walkup & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.